RUA Life Sciences (LSE:RUA) COGS-to-Revenue : 0.17 (As of Sep. 2024)

View and export this data going back to 2002. Start your Free Trial

What is RUA Life Sciences COGS-to-Revenue?

RUA Life Sciences's Cost of Goods Sold for the six months ended in Sep. 2024 was £0.26 Mil. Its Revenue for the six months ended in Sep. 2024 was £1.52 Mil.

RUA Life Sciences's COGS to Revenue for the six months ended in Sep. 2024 was 0.17.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. RUA Life Sciences's Gross Margin % for the six months ended in Sep. 2024 was 83.27%.

RUA Life Sciences COGS-to-Revenue Historical Data

The historical data trend for RUA Life Sciences's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RUA Life Sciences COGS-to-Revenue Chart

RUA Life Sciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

Get a 7-Day Free Trial

0.18

0.16

0.18

0.19

RUA Life Sciences Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
COGS-to-Revenue	Get a 7-Day Free Trial															0.21	0.15	0.22	0.17	0.17

RUA Life Sciences COGS-to-Revenue Calculation

RUA Life Sciences's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.415	/	2.191
	=	0.19

RUA Life Sciences's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.255	/	1.524
	=	0.17

RUA Life Sciences (LSE:RUA) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

RUA Life Sciences's Gross Margin % for the six months ended in Sep. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.255 / 1.524
	=	83.27 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

RUA Life Sciences COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of RUA Life Sciences's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

RUA Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RUA Life Sciences PLC (LSE:RUA) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Drummond Crescent, Ayrshire, Scotland, Irvine, GBR, KA11 5AN

Website

https://www.rualifesciences.com

RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives the majority of its revenue from the USA and has a presence in Switzerland, Italy, the UK, and Israel.

RUA Life Sciences Headlines

No Headlines